Sigmatic Sciences Powers AI Scientists with NVIDIA's Latest BioNeMo Agentic Capabilities

Sigmatic Sciences announced an integration of NVIDIA’s BioNeMo Agent Toolkit into its SigmaticOS platform, expanding its life-sciences AI workflow capabilities. The company says the update strengthens its “AI Scientist” approach by connecting AI agents with scientific software, lab systems, proprietary data, and automation tools in a traceable, lab-in-the-loop discovery workflow. SigmaticOS already used NVIDIA BioNeMo and Nemotron models in production, and now adds more orchestration across biological AI models and laboratory environments. The release emphasizes governance, reproducibility, and faster drug-discovery cycles rather than immediate financial results. For NVIDIA, the announcement underscores continued ecosystem adoption of BioNeMo in biotech and drug discovery, which could support long-term platform demand and enterprise AI positioning. No direct revenue, guidance, or product sales figures were disclosed.